ERBB2 and neoplasm: In agreement with the presence of HER2 gene amplification detected by FISH analysis, the case PA4 demonstrates 3+ score positivity, showing strong complete or basolateral membrane immunoreactivity in 90% of tumor cells (Figure 3B; Table 2)